• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.P2Y(2) 受体沉默可降低新西兰兔眼内压。
Br J Pharmacol. 2012 Feb;165(4b):1163-72. doi: 10.1111/j.1476-5381.2011.01586.x.
2
Hypotensive effect of UDP on intraocular pressure in rabbits.尿苷二磷酸对兔眼压的降压作用。
Eur J Pharmacol. 2008 Jan 28;579(1-3):93-7. doi: 10.1016/j.ejphar.2007.10.040. Epub 2007 Oct 25.
3
Silencing of P2Y2 receptor delays Ap4A-corneal re-epithelialization process.P2Y2受体沉默会延迟Ap4A诱导的角膜再上皮化过程。
Mol Vis. 2009 Jun 11;15:1169-78.
4
Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells.嘌呤能 P2Y2 受体介导人血管内皮细胞中钙(Ca2+)的快速动员、膜超极化和一氧化氮(NO)的产生。
Cell Calcium. 2011 Apr;49(4):240-8. doi: 10.1016/j.ceca.2011.02.008. Epub 2011 Mar 16.
5
Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor.三磷酸尿苷通过激活 P2Y2 受体增加人胰腺导管癌细胞的增殖。
Pancreas. 2013 May;42(4):680-6. doi: 10.1097/MPA.0b013e318271bb4b.
6
Enhancement of acid-sensing ion channel activity by metabotropic P2Y UTP receptors in primary sensory neurons.代谢型P2Y UTP受体增强初级感觉神经元中酸敏感离子通道的活性。
Purinergic Signal. 2016 Mar;12(1):69-78. doi: 10.1007/s11302-015-9479-y. Epub 2015 Nov 5.
7
Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate.使用稳定嘧啶尿苷5'-O-硫代二磷酸酯和尿苷5'-O-3-硫代三磷酸酯对人冠状动脉中收缩性P2受体进行表征。
J Pharmacol Exp Ther. 2000 Jun;293(3):755-60.
8
The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors.稳定的嘧啶UDPβS和UTPγS可区分收缩性脑血管P2受体。
Eur J Pharmacol. 2003 Jan 5;458(3):305-11. doi: 10.1016/s0014-2999(02)02787-5.
9
A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist.一种基于 P2Y6 受体激动剂的治疗青光眼的有前途的候选药物。
Purinergic Signal. 2018 Sep;14(3):271-284. doi: 10.1007/s11302-018-9614-7. Epub 2018 Jul 17.
10
Cold storage of rabbit thoracic aorta in University of Wisconsin solution attenuates P2Y(2) purine receptors.在威斯康星大学溶液中对兔胸主动脉进行冷藏会使P2Y(2)嘌呤受体功能减弱。
Cryobiology. 2002 Apr;44(2):91-102. doi: 10.1016/s0011-2240(02)00010-x.

引用本文的文献

1
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach.青光眼治疗新药理学靶点的鉴定:一种网络药理学方法。
Pharmaceuticals (Basel). 2024 Oct 5;17(10):1333. doi: 10.3390/ph17101333.
2
Engineered sensor actuator modulator as aqueous humor outflow actuator for gene therapy of primary open-angle glaucoma.工程传感器执行器调制器作为房水流出执行器用于原发性开角型青光眼的基因治疗。
J Transl Med. 2024 Aug 28;22(1):791. doi: 10.1186/s12967-024-05581-1.
3
Conjunctival Fluid Secretion Impairment via CaCC-CFTR Dysfunction Is the Key Mechanism in Environmental Dry Eye.通过钙激活氯离子通道-囊性纤维化跨膜电导调节因子功能障碍导致的眼表液分泌减少是环境干燥性眼表疾病的关键发病机制。
Int J Mol Sci. 2022 Nov 19;23(22):14399. doi: 10.3390/ijms232214399.
4
Animal Model Contributions to Primary Congenital Glaucoma.动物模型对原发性先天性青光眼的贡献。
J Ophthalmol. 2022 May 26;2022:6955461. doi: 10.1155/2022/6955461. eCollection 2022.
5
Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.嘌呤能 P2Y2 受体在肺动脉高压中的作用。
Int J Environ Res Public Health. 2021 Oct 20;18(21):11009. doi: 10.3390/ijerph182111009.
6
Efficacy of Artificial Tears Based on an Extract of Containing Dinucleotides in a Rabbit Dry Eye Model.含二核苷酸提取物的人工泪液对兔干眼症模型的疗效。
Int J Mol Sci. 2021 Nov 5;22(21):11999. doi: 10.3390/ijms222111999.
7
Gene Therapy in the Anterior Eye Segment.眼前节的基因治疗。
Curr Gene Ther. 2022;22(2):104-131. doi: 10.2174/1566523221666210423084233.
8
Changes in P2Y Purinergic Receptor Expression in the Ciliary Body in a Murine Model of Glaucoma.青光眼小鼠模型中睫状体P2Y嘌呤能受体表达的变化
Front Pharmacol. 2017 Oct 10;8:719. doi: 10.3389/fphar.2017.00719. eCollection 2017.
9
Purinergic dysregulation causes hypertensive glaucoma-like optic neuropathy.嘌呤能调节紊乱导致高血压性青光眼样视神经病变。
JCI Insight. 2017 Oct 5;2(19):93456. doi: 10.1172/jci.insight.93456.
10
Diadenosine tetraphosphate as a potential therapeutic nucleotide to treat glaucoma.四磷酸二腺苷作为治疗青光眼的一种潜在治疗性核苷酸。
Purinergic Signal. 2017 Jun;13(2):171-177. doi: 10.1007/s11302-016-9547-y. Epub 2016 Nov 16.

本文引用的文献

1
Guide to Receptors and Channels (GRAC), 5th edition.《受体和离子通道手册》(GRAC)第 5 版。
Br J Pharmacol. 2011 Nov;164 Suppl 1(Suppl 1):S1-324. doi: 10.1111/j.1476-5381.2011.01649_1.x.
2
Glaucoma patients present increased levels of diadenosine tetraphosphate, Ap(4)A, in the aqueous humour.青光眼前房水中二磷酸四腺苷(Ap(4)A)水平升高。
Exp Eye Res. 2011 Mar;92(3):221-6. doi: 10.1016/j.exer.2010.12.004. Epub 2010 Dec 10.
3
Adenine nucleotide effect on intraocular pressure: Involvement of the parasympathetic nervous system.腺嘌呤核苷酸对眼压的影响:副交感神经系统的参与。
Exp Eye Res. 2009 Jun 15;89(1):63-70. doi: 10.1016/j.exer.2009.02.010. Epub 2009 Feb 27.
4
New treatments for ocular hypertension.眼压过高的新疗法。
Auton Neurosci. 2009 May 11;147(1-2):14-9. doi: 10.1016/j.autneu.2008.12.009. Epub 2009 Jan 26.
5
Nucleotides in ocular secretions: their role in ocular physiology.眼分泌物中的核苷酸:它们在眼生理学中的作用。
Pharmacol Ther. 2008 Jul;119(1):55-73. doi: 10.1016/j.pharmthera.2008.04.002. Epub 2008 May 11.
6
Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor.鉴定孤儿G蛋白偶联受体P2Y(10)受体为1-磷酸鞘氨醇和溶血磷脂酸受体。
Biochem Biophys Res Commun. 2008 Jul 11;371(4):707-12. doi: 10.1016/j.bbrc.2008.04.145. Epub 2008 May 6.
7
Immunolocalisation of P2Y receptors in the rat eye.P2Y 受体在大鼠眼中的免疫定位。
Purinergic Signal. 2004 Dec;1(1):83-90. doi: 10.1007/s11302-004-5072-5.
8
hGPR87 contributes to viability of human tumor cells.人GPR87对人肿瘤细胞的生存能力有贡献。
Int J Cancer. 2008 May 1;122(9):2008-16. doi: 10.1002/ijc.23349.
9
Hypotensive effect of UDP on intraocular pressure in rabbits.尿苷二磷酸对兔眼压的降压作用。
Eur J Pharmacol. 2008 Jan 28;579(1-3):93-7. doi: 10.1016/j.ejphar.2007.10.040. Epub 2007 Oct 25.
10
Effect of cellular senescence on the P2Y-receptor mediated calcium response in trabecular meshwork cells.细胞衰老对小梁网细胞中P2Y受体介导的钙反应的影响。
Mol Vis. 2007 Oct 16;13:1926-33.

P2Y(2) 受体沉默可降低新西兰兔眼内压。

Silencing of P2Y(2) receptors reduces intraocular pressure in New Zealand rabbits.

机构信息

Departamento de Bioquímica y Biología Molecular IV, E.U. Óptica, Universidad Complutense de Madrid, Madrid, Spain.

出版信息

Br J Pharmacol. 2012 Feb;165(4b):1163-72. doi: 10.1111/j.1476-5381.2011.01586.x.

DOI:10.1111/j.1476-5381.2011.01586.x
PMID:21740413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3346251/
Abstract

BACKGROUND AND PURPOSE

P2 receptors are involved in the regulation of ocular physiological processes like intraocular pressure (IOP). In the present study, the involvement of P2Y(2) receptors in the hypertensive effect of nucleotides was investigated by use of antagonists and of a siRNA designed for the P2Y(2) receptor.

EXPERIMENTAL APPROACH

Agonists of the P2Y(2) receptor a as well as P2 antagonists were applied to eyes of New Zealand rabbits, and the changes in IOP were followed for up to 6 h. Cloning of the P2Y(2) receptor cDNA was done using a combination of degenerate reverse transcription PCR (RT-PCR) and rapid amplification of cDNA ends (RACE). siRNA was synthesized and tested by immunohistochemistry.

KEY RESULTS

Single doses of 2-thioUTP, UTP-γ-S and UTP increased IOP. This behaviour was concentration-dependent and partially antagonized by reactive blue 2. Silencing the P2Y(2) receptor was observed in the ciliary body by immunohistochemistry labelling, where a reduction in the immunofluorescence was observed. This reduction in the expression of the P2Y(2) receptor was concomitant with a reduction in IOP, which was measurable 24 h after treatment with the siRNA, maximal after 2 days, followed by a slow increase towards control values for the following 5 days. Application of the P2Y(2) agonists after pretreatment of the animals with this siRNA did not produce any change in IOP.

CONCLUSIONS AND IMPLICATIONS

P2Y(2) receptors increase IOP in New Zealand rabbits. The application of a siRNA for this receptor significantly reduced IOP, suggesting that this technology might be used for the treatment of glaucoma.

摘要

背景与目的

P2 受体参与调节眼内压(IOP)等生理过程。本研究通过使用拮抗剂和针对 P2Y(2)受体的 siRNA,研究了 P2Y(2)受体在核苷酸致高血压效应中的作用。

实验方法

将 P2Y(2)受体激动剂 a 以及 P2 拮抗剂应用于新西兰兔眼,观察 IOP 的变化,最长可达 6 小时。采用简并逆转录 PCR(RT-PCR)和快速扩增 cDNA 末端(RACE)的方法克隆 P2Y(2)受体 cDNA。siRNA 通过免疫组织化学进行合成和测试。

主要结果

单次给予 2-硫代尿苷三磷酸(2-thioUTP)、UTP-γ-S 和 UTP 均可升高 IOP。这种作用呈浓度依赖性,部分被反应性蓝 2 拮抗。免疫组织化学标记观察到睫状体 P2Y(2)受体的沉默,观察到免疫荧光减弱。这种 P2Y(2)受体表达的减少与 IOP 的降低同时发生,在 siRNA 处理后 24 小时即可测量到,2 天后达到最大值,随后在接下来的 5 天内缓慢增加至对照值。在用这种 siRNA 预处理动物后,应用 P2Y(2)激动剂不会引起 IOP 的任何变化。

结论和意义

P2Y(2)受体可使新西兰兔眼内压升高。针对该受体的 siRNA 的应用显著降低了 IOP,提示该技术可能用于治疗青光眼。